MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2024 Earnings Call Transcript May 14, 2024
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-110.07431 EPS, expectations were $-0.16.
Operator: Good morning, and welcome to the MiNK Therapeutics’ First Quarter 2024 Conference Call and Webcast. [Operator Instructions]. Please note this event is being recorded. If anyone has any objections you may disconnect at this time. I would now like to turn the conference over to Zack...
